1. Home
  2. NVAX vs PD Comparison

NVAX vs PD Comparison

Compare NVAX & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PD
  • Stock Information
  • Founded
  • NVAX 1987
  • PD 2009
  • Country
  • NVAX United States
  • PD United States
  • Employees
  • NVAX N/A
  • PD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PD Computer Software: Prepackaged Software
  • Sector
  • NVAX Health Care
  • PD Technology
  • Exchange
  • NVAX Nasdaq
  • PD Nasdaq
  • Market Cap
  • NVAX 1.3B
  • PD 1.4B
  • IPO Year
  • NVAX 1995
  • PD 2019
  • Fundamental
  • Price
  • NVAX $6.66
  • PD $15.68
  • Analyst Decision
  • NVAX Buy
  • PD Buy
  • Analyst Count
  • NVAX 6
  • PD 11
  • Target Price
  • NVAX $17.83
  • PD $20.55
  • AVG Volume (30 Days)
  • NVAX 8.5M
  • PD 1.1M
  • Earning Date
  • NVAX 05-08-2025
  • PD 05-29-2025
  • Dividend Yield
  • NVAX N/A
  • PD N/A
  • EPS Growth
  • NVAX N/A
  • PD N/A
  • EPS
  • NVAX 2.97
  • PD N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • PD $467,499,000.00
  • Revenue This Year
  • NVAX N/A
  • PD $10.97
  • Revenue Next Year
  • NVAX N/A
  • PD $9.15
  • P/E Ratio
  • NVAX $2.24
  • PD N/A
  • Revenue Growth
  • NVAX 25.92
  • PD 8.54
  • 52 Week Low
  • NVAX $4.43
  • PD $14.30
  • 52 Week High
  • NVAX $23.86
  • PD $23.12
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.25
  • PD 47.71
  • Support Level
  • NVAX $5.82
  • PD $14.72
  • Resistance Level
  • NVAX $6.61
  • PD $15.84
  • Average True Range (ATR)
  • NVAX 0.53
  • PD 0.49
  • MACD
  • NVAX 0.02
  • PD 0.11
  • Stochastic Oscillator
  • NVAX 42.21
  • PD 81.42

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

Share on Social Networks: